Monoclonal antibody-defined circulating human tumor-associated antigen with epitope shared by cytokeratins.
Sera of human colonic carcinoma xenografted rnu/nu rats were used to immunize rnu/+rats in order to obtain an immune response against circulating human tumor-associated components. After fusion of rat spleen cells with mouse myeloma cells monoclonal antibody MAB 108 could be established which reacted with two 40 and 45 kD cytokeratins as well as with vimentin, with a soluble 37 kD protein apparently derived from the 45 kD protein and with a 37 kD protein released by tumor cells. The MAB 108-specific epitope was also detected in tissue polypeptide antigen (TPA), a human tumor-associated antigen originally described by Björklund et al. (22).
Hollmann
M
M
Staab
H J
HJ
Spindler
E
E
Sproll
M
M
Anderer
F A
FA
Fortmeyer
H P
HP
D000818:Animals; D000911:Antibodies, Monoclonal; D002460:Cell Line; D003110:Colonic Neoplasms / Q000276:immunology*; D004591:Electrophoresis, Polyacrylamide Gel; D000939:Epitopes / Q000032:analysis*; D006801:Humans; D007633:Keratins / Q000276:immunology*; D051379:Mice; D008970:Molecular Weight; D009368:Neoplasm Transplantation; D010455:Peptides / Q000032:analysis; D051381:Rats; D019396:Tissue Polypeptide Antigen
D000911:Antibodies, Monoclonal; D000939:Epitopes; D010455:Peptides; D019396:Tissue Polypeptide Antigen; D007633:Keratins